Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when NMTC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNeuroOne Medical announces Q1 FY2026 financial results for quarter ended March 31, 2026
Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read
Key Changes
-
medium
Company issued press release disclosing financial results for fiscal quarter ended March 31, 2026. Specific revenue, earnings, and operational metrics are contained in the attached press release.
Item 2.02 verify on EDGAR → -
medium
The 8-K filing itself contains no financial figures or business updates; all material information is in the attached press release exhibit.
Exhibit 99.1 view on EDGAR →
Summary
NeuroOne Medical Technologies filed an 8-K to announce its first quarter fiscal 2026 financial results for the period ended March 31, 2026. This is a routine quarterly earnings disclosure required by SEC rules. The filing references a press release dated May 12, 2026, but the 8-K body does not include the actual financial figures, revenue numbers, or operational updates.
Retail investors should review the full press release (Exhibit 99.1) to understand the company's quarterly performance, including revenue trends, cash position, and any forward guidance provided by management. As a medical technology company, key metrics to watch include product sales growth, regulatory milestones, and cash burn rate. The next quarterly update will cover the period ending June 30, 2026.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 12, 2026, NeuroOne Medical Technologies Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026.
The company disclosed its financial results for the fiscal quarter ended March 31, 2026 through a press release. The actual financial figures are contained in the referenced press release (Exhibit 99.1), which is not included in this 8-K body text.
Event · Item 9.01 — Financial Statements and Exhibits
NEUROONE filed an 8-K attaching a press release dated May 12, 2026; no material business event disclosed in the filing body.
Added in current filing · verify on EDGAR →
Exhibit No. | Description | 99.1 | Press Release, dated May 12, 2026
The 8-K attaches a press release dated May 12, 2026 as Exhibit 99.1. The filing body itself contains no disclosure of the press release content or the underlying corporate event being announced. Without access to Exhibit 99.1, the nature and materiality of the announcement cannot be determined from this filing.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify